SWITCHING FROM STATIN MONOTHERAPY TO EZETIMIBE/SIMVASTATIN OR ROSUVASTATIN MODIFIES THE RELATIONSHIPS BETWEEN APOLIPOPROTEIN B, LDL CHOLESTEROL, ANC NON-HDL CHOLETEROL IN PATIENTS AT HIGH RISK OF CORONARY DISEASE

Maurizio Averna, Luc Missault, Margus Viigimaa, Philippe Brudi, Arvind Shah, Qian Dong, Arvind Shah, Margus Viigimaa, Margus Viigimaa, Amy O. Johnson-Levonas, Helena Vaverkova, Michel Farnier, Maurizio Averna

Risultato della ricerca: Articlepeer review

3 Citazioni (Scopus)

Fingerprint

Entra nei temi di ricerca di 'SWITCHING FROM STATIN MONOTHERAPY TO EZETIMIBE/SIMVASTATIN OR ROSUVASTATIN MODIFIES THE RELATIONSHIPS BETWEEN APOLIPOPROTEIN B, LDL CHOLESTEROL, ANC NON-HDL CHOLETEROL IN PATIENTS AT HIGH RISK OF CORONARY DISEASE'. Insieme formano una fingerprint unica.

Medicine & Life Sciences

Chemical Compounds